siRNA, Anti-SYNGR1, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT26817WQ-2OMe)

The product SIRGT26817WQ-2OMe is a type of small interfering RNA (siRNA) that targets SYNGR1 gene and regulates the expression of gene. The siRNA interferes with the expression of SYNGR1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_004711.4; NM_145731.3; NM_145738.2
Related Diseases Megalencephalic Leukoencephalopathy With Subcortical Cysts
Purification HPLC
Target Gene
Gene ID 9145
Uniprot ID O43759
Sub Cat Target Species Modification Scale  
SIRGT27817WQ-2F SYNGR1 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT28817WQ-2MOE SYNGR1 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT29817WQ-LNA SYNGR1 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT26817WQ-RB SYNGR1 Human Ribo-modified Inquiry
SIRGT27817WQ-BB SYNGR1 Human Backbone-modified Inquiry

Related Products